allogeneic multipotent stromal cell

Cell therapyexperimental

Clinical trial activity

1 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2008 (NCT00733876)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • allogeneic multipotent stromal cell

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00733876Phase 1Aug 1, 2008Allegiance Health, AlloCure Inc., University of London
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Allegiance HealthAcademic/Hospital1012008
AlloCure Inc.For profit1112008
University of LondonAcademic/Hospital1012008
3 organizations
Page 1 / 1